teleo-codex/inbox/queue/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey.md
Teleo Agents 361cd86537 vida: research session 2026-05-11 — 8 sources archived
Pentagon-Agent: Vida <HEADLESS>
2026-05-11 04:17:06 +00:00

6.3 KiB

type title author url date domain secondary_domains format status priority tags intake_tier
source Oregon's Psilocybin Facilitator Workforce: Survey of First Legal Facilitators and Training Programs Journal of Psychoactive Drugs (PMC12304229) https://pmc.ncbi.nlm.nih.gov/articles/PMC12304229/ 2025-01-29 health
peer-reviewed unprocessed high
psilocybin
Oregon
facilitator-workforce
scalability
access
training
equity
research-task

Content

Study design: Survey of first cohort of Oregon psilocybin facilitator trainees and licensed facilitators. N=106 respondents. Survey conducted 2023, published January 2025.

Facilitator licensing status at time of survey:

  • Only 16 of 106 (15.1%) had obtained Oregon facilitator license — reflects early-stage program

Training program landscape:

  • 16 active programs identified with functional websites
  • Tuition range: $4,500-$12,000 (mean: $9,359)
  • Duration: 80-200 hours coursework + 40-hour practicum; modal program ~120 hours + 40 practicum over ~8 months
  • 50% of programs offered scholarships for equity/inclusion
  • Financial strain: 79% reported training costs created moderate-to-severe financial strain

Facilitator workforce demographics:

  • Race/ethnicity: 64.4% white; 35.6% people of color (more diverse than client population)
  • Gender: 40% women, 40% men, 20% other/LGBTQ+
  • Education: 72.5% held graduate degrees
  • Age: Mean 42.8 years
  • Income: 32.5% earned $50,000-$99,999 annually
  • Healthcare licenses: 57.3% possessed existing healthcare credentials

Capacity and practice parameters:

  • Mean intended weekly service hours: 18.6 hours
  • Intended monthly clients: approximately 10 per facilitator
  • Mean planned session cost: $1,388 per session (below current market of $1,500-3,000)
  • Specialization interests: Trauma (83%), mental health disorders (69%), consciousness exploration (68%)

Scalability calculation (derived):

  • At 10 clients/month, each licensed facilitator can serve ~120 clients/year
  • Oregon had ~500 licensed facilitators as of Q1 2026 → ~60,000 clients/year Oregon capacity
  • Oregon's Q1 2025 rate: 1,509 clients in 4 months → ~4,500/year Oregon run rate
  • Oregon is at ~7.5% of theoretical facilitator capacity — not a capacity constraint yet at current demand
  • But US-level TRD population is 7 million → scaling nationally requires orders-of-magnitude more facilitators

Structural bottleneck analysis:

  • Training costs ($9,359 mean) + 160 hours minimum + $2,000/year licensing + $10,000+ regulatory fees for service centers
  • $12,000 liability insurance per facilitator opening a center
  • Equity concern: high training costs filter toward already-credentialed healthcare workers

Agent Notes

Why this matters: This is the first empirical data on the facilitator pipeline that will determine whether psilocybin therapy can scale beyond the current high-income, urban, white user base. The key finding: facilitators are diverse (35.6% POC — more than clients), but the training cost barrier ($9,359 mean with 79% reporting moderate-to-severe financial strain) filters toward people who already have financial resources and healthcare credentials.

What surprised me: The Oregon capacity utilization figure: Oregon has ~500 facilitators with capacity for ~60,000 clients/year, but is only serving ~4,500/year. This means Oregon's psilocybin access gap is NOT primarily a supply-side capacity problem — it's a demand-side cost and coverage problem. The facilitators are there; people can't afford the sessions.

What I expected but didn't find: Evidence that capacity constraints are limiting access. The problem is cost/affordability, not facilitator availability. This inverts the typical healthcare access story (where supply — doctors, clinics — is the constraint).

KB connections:

Extraction hints:

  • New claim: "Oregon's psilocybin access gap is a demand-side cost failure, not a supply-side capacity problem — facilitators have capacity for 60,000 clients/year but only 4,500/year are being served because session costs ($1,200-3,000) are uninsured and out-of-pocket"
  • The 79% facilitator financial strain during training is itself a claim candidate: it filters toward economically privileged trainees despite the program's equity intentions
  • The 35.6% facilitator POC representation (vs. 12.5% client POC representation) creates an ironic inversion: the workforce is more diverse than the clientele it serves

Context: Journal of Psychoactive Drugs — established, peer-reviewed journal for substance use and psychedelic research. Published January 2025. Survey represents Oregon's first cohort of facilitators during 2023, so reflects early-stage program status. Current facilitator count (~500 as of 2026) exceeds the 16/106 licensed at survey time.

Curator Notes (structured handoff for extractor)

PRIMARY CONNECTION: the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access WHY ARCHIVED: Provides the most rigorous data available on the psilocybin facilitator pipeline — both its demographics and its scalability constraints. The demand-side vs. supply-side diagnosis (capacity exists, cost is the barrier) is analytically important and potentially counter-intuitive. EXTRACTION HINT: The key insight is the INVERSION from typical healthcare access analysis. Oregon is not supply-constrained for psilocybin services — it is cost-constrained on the demand side. This matters for policy: the solution is reimbursement, not more facilitator training programs. Extract this as the primary claim. Secondary: the facilitator financial strain finding as evidence that the training pipeline itself has equity issues.